Douglas Blayney
Vermögen: 53 $ am 30.06.2026
Vermögen: 53 $ am 30.06.2026
Douglas W.
Blayney is the founder of Asco Quality Symposium.
Current positions include Independent Director at Artelo Biosciences, Inc. since 2017 and Professor-Emeritus at Stanford University since 2010.
Former positions include Medical Director and Professor-Internal Medicine at the University of Michigan Comprehensive Cancer Center from 1999 to 2003, Medical Director at Stanford Cancer Institute from 2010 to 2015, and President of the American Society of Clinical Oncology, Inc. from 2009 to 2010.
Education includes undergraduate degrees from Stanford University and the University of California.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.07.2026 | 47 ( 0% ) | 53 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 31.07.2017 |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.07.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
Stanford Cancer Institute
Stanford Cancer Institute Miscellaneous Commercial ServicesCommercial Services Operates as an NCI-designated center for translating cancer research into improved patient outcomes | Corporate Officer/Principal | 01.07.2015 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Präsident | 01.07.2010 |
University of Michigan Comprehensive Cancer Center
University of Michigan Comprehensive Cancer Center Other Consumer ServicesConsumer Services Functions as a College/University | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2003 |
Asco Quality Symposium | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Artelo Biosciences, Inc.
Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
University of Michigan Comprehensive Cancer Center
University of Michigan Comprehensive Cancer Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Cancer Institute
Stanford Cancer Institute Miscellaneous Commercial ServicesCommercial Services Operates as an NCI-designated center for translating cancer research into improved patient outcomes | Commercial Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asco Quality Symposium |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen